Milford MA. – Prestige Scientific is excited to announce the successful completion of a search for a Vice President of Clinical Pharmacology for our rapidly growing biotechnology partner pioneering a new and differentiated class of therapeutics.
This influential Vice President of Clinical Pharmacology will lead our client’s clinical pharmacology function and soon grow to lead many other aspects of the preclinical process. This is a key appointment that will drive multidisciplinary drug development project teams and will provide subject matter expertise in quantitative pharmacology. This role will help drive an oncology portfolio of highly novel peptide therapeutics. "Our client is one of the most exciting and scientifically intriguing biotech’s in the area. They are developing an entirely new class of medicines that could change the way we treat certain cancers. We are ecstatic about playing our part in helping build such an important team with the potential to change the lives of so many patients in need,” said Michael Barros, Managing Partner of Prestige Scientific.
Prestige Scientific is the trusted advisor to this clinical-stage biopharmaceutical company developing a novel class of medicines derived from science first conceived in the laboratory of the 2018 Nobel Prize winner in Chemistry. Prestige has since successfully secured a Chief Medical Officer, VP Clinical Development, Director Clinical Sciences, as well as clinical operations and program management hires.
Congratulations to Michael Barros and Evan Hansberry for leading this search! Get in touch with Michael, mbarros@prestigescientific.com, or Evan, evanh@prestigescientific.com, or find us on LinkedIn.
About Prestige Scientific:
Prestige Scientific is an executive search firm that advises our clients on recruiting impactful leaders. We provide our clients with a performance-based hiring system that identifies leaders with past success meeting similar corporate objectives as their own, while overcoming challenges and adhering to critical timelines. We have dedicated experts in eleven practice areas that mirror a typical biopharma company, allowing us to support our client's growth from Discovery through Commercial.
